糖鎖治療薬の世界市場レポート 2023年以下を含む1) クラス別単離; 合成2) 構造別:糖タンパク質;シアル酸を標的とする;プロテオグリカン;グリコサミノグリカンを標的とする;グリコシルホスファチジルイノシトール(GPI)アンカータンパク質およびヘパリンベースの糖鎖を標的とする;スフィンゴ糖脂質を標的とする3)作用機序別:ノイラミニダーゼを阻害する;ヘパラナーゼおよびセレクチンを阻害し、成長因子とヘパラン硫酸との相互作用を阻害する;エリスロポエチンおよび酵素補充療法(ERT);組織プラスミノーゲン活性化因子;グルコシルセラミド合成酵素を阻害する;インターロイキン1、2および3;ベータおよびガンマインターフェロン4):血栓症および化学予防;貧血;抗接着および抗炎症;白内障;ゴーシェ病;Mps-1およびIV;がん;アルツハイマー病;A型インフルエンザおよびBCovering:エフ・ホフマン・ラ・ロシュ社、バイエル社、サノフィ社、サーモフィッシャーサイエンティフィック社、グラクソ・スミスクライン社Glycomic Therapeutics Global Market Report 2023Including: 1) By Class: Isolated; Synthetic2) By Structures: Glycoproteins; Targeting Sialic Acid; Proteoglycans; Targeting Glycosaminoglycans; Glycosylphosphatidylinositol (GPI)-Anchored Proteins And Heparin Based Glycans; Targeting Glycosphingolipids3) By Mode Of Action: Inhibits Neuraminidase; Inhibits Heparanase And Selectins And Blocks Interactions Between Growth Factors And Heparan Sulfate; Erythropoietin And Enzyme Replacement Therapy (ERT); Tissue Plasminogen Activator; Inhibits Glucosylceramide Synthase; Interleukin 1, 2 And 3; Beta And Gamma Interferons4) By Indications: Thrombosis And Chemoprophylaxis; Anemia; Anti-Adhesive And Anti-Inflammatory; Cataracts; Gauchers Disease; Mps-1 And IV; Cancer; Alzheimers Disease; Influenza Type A And BCovering: F Hoffmann-La Roche Ltd.; Bayer AG; Sanofi SA; Thermo Fisher Scientific Inc.; GlaxoSmithKline plc ビジネスリサーチ社の糖鎖治療薬の世界市場レポート2023年版は、戦略担当者、マーケティング担当者、上級管理職が市場を評価するために必要な重要情報を提供します。 このレポートは力強い成長を遂げている糖... もっと見る
サマリービジネスリサーチ社の糖鎖治療薬の世界市場レポート2023年版は、戦略担当者、マーケティング担当者、上級管理職が市場を評価するために必要な重要情報を提供します。このレポートは力強い成長を遂げている糖鎖治療薬市場に焦点を当てています。今後10年間およびそれ以降の市場を形成するトレンドのガイドを提供します。 購入の理由 - 50以上の地域をカバーするこの市場に関する最も包括的なレポートにより、真にグローバルな視点を得ることができます。 - 市場がCOVID-19の影響をどのように受けてきたか、またウイルスの影響が和らぐにつれて市場がどのように対応しているかを理解する。 - ロシア・ウクライナ戦争が農業、エネルギー、鉱物資源供給に与える影響と、市場への直接的・間接的影響を評価する。 - 世界的な高インフレが市場成長に与える影響を測定する。 - 現地のデータと分析に基づき、地域戦略と国別戦略を策定する。 - 投資の対象となる成長セグメントを特定する。 - 予測データと市場を形成する原動力とトレンドを活用し、競合他社を凌駕する。 - 最新の市場シェアに基づいて顧客を理解する。 - 主要な競合他社に対する業績のベンチマーク - 信頼性の高い高品質のデータと分析により、社内外でのプレゼンテーションをサポートするのに適しています。 - レポートは最新データに更新され、データ抽出と分析が簡単にできるExcelデータシートとともに、ご注文から3~5営業日以内にお届けします。 - レポートの全データは、エクセルのダッシュボード形式でも納品されます。 説明 糖鎖治療薬の最大かつ最速の成長市場はどこか?経済全体、人口動態、他の類似市場との関連は?今後どのような力が市場を形成していくのか?この調査レポートは糖鎖治療薬の世界市場を分析・予測したビジネス調査報告書です。 市場の特徴、規模と成長、セグメンテーション、地域別および国別内訳、競合環境、市場シェア、トレンド、戦略を網羅しています。地域別に市場の過去および予測市場成長を追跡します。 - 市場特性のセクションでは、市場を定義し説明しています。 - 市場規模のセクションでは、市場の歴史的な成長と発展の予測の両方をカバーする市場規模(bドル)を示します。 - 予測は、現在市場に影響を与えている主な要因を考慮した上で行っています。これらには以下が含まれる: - ロシア・ウクライナ戦争による制裁措置、サプライチェーンの混乱、商品・サービス需要の変化による影響、東欧地域の様々なマクロ経済要因やパラメータへの影響、その後の世界市場への影響。 - 多くの国々におけるインフレ率の上昇とそれに伴う金利の急上昇の影響。 - COVID-19がサプライチェーンと消費パターンに与える影響の継続と減少。 - 市場セグメンテーションでは、市場をサブマーケットに分類している。 - 地域別および国別の内訳では、各地域の市場分析と地域別の市場規模を示し、それらの過去および予測成長率を比較している。全地域、主要先進国、主要新興国のCOVID-19の成長軌跡を網羅しています。 - 競合環境の章では、市場の競合性、市場シェア、主要企業について解説しています。近年市場を形成してきた主要な金融取引についても明らかにしている。 - トレンドと戦略の章では、危機から脱した市場の形状を分析し、市場が回復する中で企業がどのように成長できるかを示唆している。 調査範囲 対象市場:1)クラス別アイソレーテッド; シンセティック 2) 構造別糖タンパク質;シアル酸標的;プロテオグリカン;グリコサミノグリカン標的;グリコシルホスファチジルイノシトール(GPI)アンカータンパク質およびヘパリンベースの糖鎖;スフィンゴ糖脂質標的;その他の構造 3) 作用機序ノイラミニダーゼの阻害;ヘパラナーゼおよびセレクチンの阻害および成長因子とヘパラン硫酸との相互作用の阻害;エリスロポエチンおよび酵素補充療法(ERT);組織プラスミノーゲン活性化因子;グルコシルセラミド合成酵素の阻害;インターロイキン1、2および3;βおよびγインターフェロン;その他の作用機序 4) 効能・効果血栓症および化学予防;貧血;抗接着および抗炎症;白内障;ゴーシェ病;Mps-1およびIV;がん;アルツハイマー病;A型およびB型インフルエンザ;その他の適応症 言及された企業ホフマン・ラ・ロシュ社、バイエル社、サノフィ社、サーモフィッシャーサイエンティフィック社、グラクソ・スミスクライン社 国名オーストラリア、ブラジル、中国、フランス、ドイツ、インド、インドネシア、日本、ロシア、韓国、英国、米国、カナダ、イタリア、スペイン 地域アジア太平洋; 西ヨーロッパ; 東ヨーロッパ; 北アメリカ; 南アメリカ; 中東; アフリカ 時系列:過去5年間および過去10年間の予測。 データ市場規模と成長率の関連市場に対する比率、GDP比率、一人当たり支出、 データ区分:国別・地域別の過去データと予測データ、競合他社の市場シェア、市場セグメント。 ソーシングと参照:本レポート中のデータおよび分析は、エンドノートを使用しています。 納品形式PDF、Word、Excel データダッシュボード。 目次1. Executive Summary2. Glycomic Therapeutics Market Characteristics 3. Glycomic Therapeutics Market Trends And Strategies 4. Glycomic Therapeutics Market - Macro Economic Scenario 4.1. Impact Of High Inflation On Online Therapy Services Market 4.2. Ukraine-Russia War Impact On Online Therapy Services Market 4.3. COVID-19 Impact On Online Therapy Services Market 5.1. Global Glycomic Therapeutics Historic Market Size and Growth, 2017 - 2022, Value ($ Billion) 5.2. Global Glycomic Therapeutics Forecast Market Size and Growth, 2022 - 2027, 2032F, Value ($ Billion) 5.3. Global Glycomic Therapeutics Market Drivers and Restraints 5.3.1. Drivers Of The Market 5.3.2. Restraints Of The Market 6. Glycomic Therapeutics Market Segmentation 6.1. Global Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Isolated Synthetic 6.2. Global Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Glycoproteins Targeting Sialic Acid Proteoglycans Targeting Glycosaminoglycans Glycosylphosphatidylinositol (Gpi)-Anchored Proteins And Heparin Based Glycans Targeting Glycosphingolipids Other Structures 6.3. Global Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Inhibits Neuraminidase Inhibits Heparanase And Selectins And Blocks Interactions Between Growth Factors And Heparan Sulfate Erythropoietin And Enzyme Replacement Therapy (Ert) Tissue Plasminogen Activator Inhibits Glucosylceramide Synthase Interleukin 1, 2 And 3 Beta And Gamma Interferons Other Mode Of Action 6.4. Global Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Thrombosis And Chemoprophylaxis Anaemia Anti-Adhesive And Anti-Inflammatory Cataracts Gaucher’S Disease Mps-1 And Iv Cancer Alzheimer’S Disease Influenza Type A And B Other Indications 7. Glycomic Therapeutics Market Regional And Country Analysis 7.1. Global Glycomic Therapeutics Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 7.2. Global Glycomic Therapeutics Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8. Asia-Pacific Glycomic Therapeutics Market 8.1. Asia-Pacific Glycomic Therapeutics Market Overview Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies 8.2. Asia-Pacific Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8.3. Asia-Pacific Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8.4. Asia-Pacific Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 9. China Glycomic Therapeutics Market 9.1. China Glycomic Therapeutics Market Overview 9.2. China Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 9.3. China Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 9.4. China Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 10. India Glycomic Therapeutics Market 10.1. India Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 10.2. India Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 10.3. India Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11. Japan Glycomic Therapeutics Market 11.1. Japan Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11.2. Japan Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11.3. Japan Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12. Australia Glycomic Therapeutics Market 12.1. Australia Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12.2. Australia Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12.3. Australia Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13. Indonesia Glycomic Therapeutics Market 13.1. Indonesia Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13.2. Indonesia Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13.3. Indonesia Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14. South Korea Glycomic Therapeutics Market 14.1. South Korea Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14.2. South Korea Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14.3. South Korea Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15. Western Europe Glycomic Therapeutics Market 15.1. Western Europe Glycomic Therapeutics Market Overview 15.2. Western Europe Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15.3. Western Europe Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15.4. Western Europe Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16. UK Glycomic Therapeutics Market 16.1. UK Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16.2. UK Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16.3. UK Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17. Germany Glycomic Therapeutics Market 17.1. Germany Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17.2. Germany Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17.3. Germany Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18. France Glycomic Therapeutics Market 18.1. France Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18.2. France Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18.3. France Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19. Italy Glycomic Therapeutics Market 19.1. Italy Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19.2. Italy Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19.3. Italy Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20. Spain Glycomic Therapeutics Market 20.1. Spain Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20.2. Spain Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20.3. Spain Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21. Eastern Europe Glycomic Therapeutics Market 21.1. Eastern Europe Glycomic Therapeutics Market Overview 21.2. Eastern Europe Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21.3. Eastern Europe Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21.4. Eastern Europe Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22. Russia Glycomic Therapeutics Market 22.1. Russia Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22.2. Russia Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22.3. Russia Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23. North America Glycomic Therapeutics Market 23.1. North America Glycomic Therapeutics Market Overview 23.2. North America Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23.3. North America Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23.4. North America Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24. USA Glycomic Therapeutics Market 24.1. USA Glycomic Therapeutics Market Overview 24.2. USA Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24.3. USA Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24.4. USA Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25. Canada Glycomic Therapeutics Market 25.1. Canada Glycomic Therapeutics Market Overview 25.2. Canada Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25.3. Canada Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25.4. Canada Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26. South America Glycomic Therapeutics Market 26.1. South America Glycomic Therapeutics Market Overview 26.2. South America Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26.3. South America Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26.4. South America Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27. Brazil Glycomic Therapeutics Market 27.1. Brazil Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27.2. Brazil Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27.3. Brazil Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28. Middle East Glycomic Therapeutics Market 28.1. Middle East Glycomic Therapeutics Market Overview 28.2. Middle East Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28.3. Middle East Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28.4. Middle East Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29. Africa Glycomic Therapeutics Market 29.1. Africa Glycomic Therapeutics Market Overview 29.2. Africa Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29.3. Africa Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29.4. Africa Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 30. Glycomic Therapeutics Market Competitive Landscape And Company Profiles 30.1. Glycomic Therapeutics Market Competitive Landscape 30.2. Glycomic Therapeutics Market Company Profiles 30.2.1. F Hoffmann-La Roche Ltd. 30.2.1.1. Overview 30.2.1.2. Products and Services 30.2.1.3. Strategy 30.2.1.4. Financial Performance 30.2.2. Bayer AG 30.2.2.1. Overview 30.2.2.2. Products and Services 30.2.2.3. Strategy 30.2.2.4. Financial Performance 30.2.3. Sanofi SA 30.2.3.1. Overview 30.2.3.2. Products and Services 30.2.3.3. Strategy 30.2.3.4. Financial Performance 30.2.4. Thermo Fisher Scientific Inc. 30.2.4.1. Overview 30.2.4.2. Products and Services 30.2.4.3. Strategy 30.2.4.4. Financial Performance 30.2.5. GlaxoSmithKline plc 30.2.5.1. Overview 30.2.5.2. Products and Services 30.2.5.3. Strategy 30.2.5.4. Financial Performance 31. Glycomic Therapeutics Market Other Major And Innovative Companies 31.1. Merck KGaA 31.2. ICON plc 31.3. Agilent Technologies Inc. 31.4. AMS Bio 31.5. Shimadzu Corporation 31.6. Waters Corporation 31.7. Bruker Corporation 31.8. BioMarin Pharmaceutical Inc. 31.9. Bio Techne Corp. 31.10. Promega Corporation 31.11. Halozyme Therapeutics Inc. 31.12. Takara Bio Inc. 31.13. Vector Laboratories 31.14. New England Biolabs Inc. 31.15. Protalix Biotherapeutics Inc. 32. Global Glycomic Therapeutics Market Competitive Benchmarking 33. Global Glycomic Therapeutics Market Competitive Dashboard 34. Key Mergers And Acquisitions In The Glycomic Therapeutics Market 35. Glycomic Therapeutics Market Future Outlook and Potential Analysis 35.1 Glycomic Therapeutics Market In 2027 - Countries Offering Most New Opportunities 35.2 Glycomic Therapeutics Market In 2027 - Segments Offering Most New Opportunities 35.3 Glycomic Therapeutics Market In 2027 - Growth Strategies 35.3.1 Market Trend Based Strategies 35.3.2 Competitor Strategies 36. Appendix 36.1. Abbreviations 36.2. Currencies 36.3. Historic And Forecast Inflation Rates 36.4. Research Inquiries 36.5. The Business Research Company 36.6. Copyright And Disclaimer
SummaryGlycomic Therapeutics Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market. Table of Contents1. Executive Summary2. Glycomic Therapeutics Market Characteristics 3. Glycomic Therapeutics Market Trends And Strategies 4. Glycomic Therapeutics Market - Macro Economic Scenario 4.1. Impact Of High Inflation On Online Therapy Services Market 4.2. Ukraine-Russia War Impact On Online Therapy Services Market 4.3. COVID-19 Impact On Online Therapy Services Market 5.1. Global Glycomic Therapeutics Historic Market Size and Growth, 2017 - 2022, Value ($ Billion) 5.2. Global Glycomic Therapeutics Forecast Market Size and Growth, 2022 - 2027, 2032F, Value ($ Billion) 5.3. Global Glycomic Therapeutics Market Drivers and Restraints 5.3.1. Drivers Of The Market 5.3.2. Restraints Of The Market 6. Glycomic Therapeutics Market Segmentation 6.1. Global Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Isolated Synthetic 6.2. Global Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Glycoproteins Targeting Sialic Acid Proteoglycans Targeting Glycosaminoglycans Glycosylphosphatidylinositol (Gpi)-Anchored Proteins And Heparin Based Glycans Targeting Glycosphingolipids Other Structures 6.3. Global Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Inhibits Neuraminidase Inhibits Heparanase And Selectins And Blocks Interactions Between Growth Factors And Heparan Sulfate Erythropoietin And Enzyme Replacement Therapy (Ert) Tissue Plasminogen Activator Inhibits Glucosylceramide Synthase Interleukin 1, 2 And 3 Beta And Gamma Interferons Other Mode Of Action 6.4. Global Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Thrombosis And Chemoprophylaxis Anaemia Anti-Adhesive And Anti-Inflammatory Cataracts Gaucher’S Disease Mps-1 And Iv Cancer Alzheimer’S Disease Influenza Type A And B Other Indications 7. Glycomic Therapeutics Market Regional And Country Analysis 7.1. Global Glycomic Therapeutics Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 7.2. Global Glycomic Therapeutics Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8. Asia-Pacific Glycomic Therapeutics Market 8.1. Asia-Pacific Glycomic Therapeutics Market Overview Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies 8.2. Asia-Pacific Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8.3. Asia-Pacific Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8.4. Asia-Pacific Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 9. China Glycomic Therapeutics Market 9.1. China Glycomic Therapeutics Market Overview 9.2. China Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 9.3. China Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 9.4. China Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 10. India Glycomic Therapeutics Market 10.1. India Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 10.2. India Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 10.3. India Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11. Japan Glycomic Therapeutics Market 11.1. Japan Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11.2. Japan Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11.3. Japan Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12. Australia Glycomic Therapeutics Market 12.1. Australia Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12.2. Australia Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12.3. Australia Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13. Indonesia Glycomic Therapeutics Market 13.1. Indonesia Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13.2. Indonesia Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13.3. Indonesia Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14. South Korea Glycomic Therapeutics Market 14.1. South Korea Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14.2. South Korea Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14.3. South Korea Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15. Western Europe Glycomic Therapeutics Market 15.1. Western Europe Glycomic Therapeutics Market Overview 15.2. Western Europe Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15.3. Western Europe Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15.4. Western Europe Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16. UK Glycomic Therapeutics Market 16.1. UK Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16.2. UK Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16.3. UK Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17. Germany Glycomic Therapeutics Market 17.1. Germany Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17.2. Germany Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17.3. Germany Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18. France Glycomic Therapeutics Market 18.1. France Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18.2. France Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18.3. France Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19. Italy Glycomic Therapeutics Market 19.1. Italy Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19.2. Italy Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19.3. Italy Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20. Spain Glycomic Therapeutics Market 20.1. Spain Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20.2. Spain Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20.3. Spain Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21. Eastern Europe Glycomic Therapeutics Market 21.1. Eastern Europe Glycomic Therapeutics Market Overview 21.2. Eastern Europe Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21.3. Eastern Europe Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21.4. Eastern Europe Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22. Russia Glycomic Therapeutics Market 22.1. Russia Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22.2. Russia Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22.3. Russia Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23. North America Glycomic Therapeutics Market 23.1. North America Glycomic Therapeutics Market Overview 23.2. North America Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23.3. North America Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23.4. North America Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24. USA Glycomic Therapeutics Market 24.1. USA Glycomic Therapeutics Market Overview 24.2. USA Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24.3. USA Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24.4. USA Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25. Canada Glycomic Therapeutics Market 25.1. Canada Glycomic Therapeutics Market Overview 25.2. Canada Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25.3. Canada Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25.4. Canada Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26. South America Glycomic Therapeutics Market 26.1. South America Glycomic Therapeutics Market Overview 26.2. South America Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26.3. South America Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26.4. South America Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27. Brazil Glycomic Therapeutics Market 27.1. Brazil Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27.2. Brazil Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27.3. Brazil Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28. Middle East Glycomic Therapeutics Market 28.1. Middle East Glycomic Therapeutics Market Overview 28.2. Middle East Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28.3. Middle East Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28.4. Middle East Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29. Africa Glycomic Therapeutics Market 29.1. Africa Glycomic Therapeutics Market Overview 29.2. Africa Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29.3. Africa Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29.4. Africa Glycomic Therapeutics Market, Segmentation By Indications , Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 30. Glycomic Therapeutics Market Competitive Landscape And Company Profiles 30.1. Glycomic Therapeutics Market Competitive Landscape 30.2. Glycomic Therapeutics Market Company Profiles 30.2.1. F Hoffmann-La Roche Ltd. 30.2.1.1. Overview 30.2.1.2. Products and Services 30.2.1.3. Strategy 30.2.1.4. Financial Performance 30.2.2. Bayer AG 30.2.2.1. Overview 30.2.2.2. Products and Services 30.2.2.3. Strategy 30.2.2.4. Financial Performance 30.2.3. Sanofi SA 30.2.3.1. Overview 30.2.3.2. Products and Services 30.2.3.3. Strategy 30.2.3.4. Financial Performance 30.2.4. Thermo Fisher Scientific Inc. 30.2.4.1. Overview 30.2.4.2. Products and Services 30.2.4.3. Strategy 30.2.4.4. Financial Performance 30.2.5. GlaxoSmithKline plc 30.2.5.1. Overview 30.2.5.2. Products and Services 30.2.5.3. Strategy 30.2.5.4. Financial Performance 31. Glycomic Therapeutics Market Other Major And Innovative Companies 31.1. Merck KGaA 31.2. ICON plc 31.3. Agilent Technologies Inc. 31.4. AMS Bio 31.5. Shimadzu Corporation 31.6. Waters Corporation 31.7. Bruker Corporation 31.8. BioMarin Pharmaceutical Inc. 31.9. Bio Techne Corp. 31.10. Promega Corporation 31.11. Halozyme Therapeutics Inc. 31.12. Takara Bio Inc. 31.13. Vector Laboratories 31.14. New England Biolabs Inc. 31.15. Protalix Biotherapeutics Inc. 32. Global Glycomic Therapeutics Market Competitive Benchmarking 33. Global Glycomic Therapeutics Market Competitive Dashboard 34. Key Mergers And Acquisitions In The Glycomic Therapeutics Market 35. Glycomic Therapeutics Market Future Outlook and Potential Analysis 35.1 Glycomic Therapeutics Market In 2027 - Countries Offering Most New Opportunities 35.2 Glycomic Therapeutics Market In 2027 - Segments Offering Most New Opportunities 35.3 Glycomic Therapeutics Market In 2027 - Growth Strategies 35.3.1 Market Trend Based Strategies 35.3.2 Competitor Strategies 36. Appendix 36.1. Abbreviations 36.2. Currencies 36.3. Historic And Forecast Inflation Rates 36.4. Research Inquiries 36.5. The Business Research Company 36.6. Copyright And Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
The Business Research Company (TBRC)社の医療サービス分野での最新刊レポート
本レポートと同じKEY WORD(therapeutics)の最新刊レポートよくあるご質問The Business Research Company (TBRC)社はどのような調査会社ですか?The Business Research Company (TBRC)はインドを主要拠点に世界の多様な市場を調査・予測し、調査レポートを積極的に出版しています。調査対象には技術、ライフサイエンス、重... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|